I'm sure your doctor can explain this(snort, snort).
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0070927
Abstract
Objective
Microglia
are among the first immune cells to respond to ischemic insults.
Triggering of this inflammatory response may involve the microglial
purinergic GPCR, P2Y
12, activation via extracellular release
of nucleotides from injured cells. It is also the inhibitory target of
the widely used antiplatelet drug, clopidogrel. Thus, inhibiting this
GPCR in microglia should inhibit microglial mediated neurotoxicity
following ischemic brain injury.
Methods
Experimental cerebral ischemia was induced,
in vitro with oxygen-glucose deprivation (OGD), or
in vivo via bilateral common carotid artery occlusion (BCCAO). Genetic knock-down
in vitro via siRNA, or
in vivo P2Y
12 transgenic mice (P2Y
12−/− or P2Y
12+/−), or
in vivo
treatment with clopidogrel, were used to manipulate the receptor.
Neuron death, microglial activation, and microglial migration were
assessed.
Results
The
addition of microglia to neuron-astrocyte cultures increases
neurotoxicity following OGD, which is mitigated by microglial P2Y
12 deficiency (P<0.05). Wildtype microglia form clusters around these neurons following injury, which is also prevented in P2Y
12 deficient microglia (P<0.01). P2Y
12 knock-out microglia migrated less than WT controls in response to OGD-conditioned neuronal supernatant. P2Y
12
(+/−) or clopidogrel treated mice subjected to global cerebral ischemia
suffered less neuronal injury (P<0.01, P<0.001) compared to
wild-type littermates or placebo treated controls. There were also fewer
microglia surrounding areas of injury, and less activation of the
pro-inflammatory transcription factor, nuclear factor Kappa B (NFkB).
Interpretation
P2Y
12
participates in ischemia related inflammation by mediating microglial
migration and potentiation of neurotoxicity. These data also suggest an
additional anti-inflammatory, neuroprotective benefit of clopidogrel.
No comments:
Post a Comment